PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.260
-0.060 (-4.55%)
Apr 25, 2025, 4:00 PM EDT - Market closed

PDS Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Market Capitalization
576115537623048
Upgrade
Market Cap Growth
-60.56%-60.56%-58.92%63.37%383.52%240.40%
Upgrade
Enterprise Value
373612432816115
Upgrade
Last Close Price
1.251.634.9713.208.102.14
Upgrade
PB Ratio
2.503.215.928.553.641.76
Upgrade
P/TBV Ratio
2.993.215.928.553.641.76
Upgrade
Debt / Equity Ratio
1.151.150.910.530.010.02
Upgrade
Quick Ratio
2.442.444.157.5217.378.82
Upgrade
Current Ratio
2.642.644.337.7917.809.28
Upgrade
Return on Equity (ROE)
-166.65%-166.65%-122.46%-76.21%-37.45%-76.48%
Upgrade
Return on Assets (ROA)
-43.34%-43.34%-39.45%-36.12%-27.32%-41.05%
Upgrade
Return on Capital (ROIC)
-49.99%-49.99%-45.81%-39.71%-29.31%-47.23%
Upgrade
Earnings Yield
-66.28%-61.68%-27.77%-10.86%-7.34%-31.17%
Upgrade
FCF Yield
-61.78%-57.50%-21.76%-6.83%-5.42%-27.60%
Upgrade
Buyback Yield / Dilution
-17.77%-17.77%-8.23%-11.73%-52.86%-243.98%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q